For Quick Alerts
For Daily Alerts

Wockhardt tanks 19% after USFDA import alert

By Religare

Shares of pharmaceutical firm Wockhardt Ltd fell as much as 19 per cent in the morning trade on Bombay Stock Exchaneg (BSE) after USFDA issued an "import alert" on medicines manufactured at company's plant at Aurangabad in Maharashtra following a safety inspection.

The issue of import alert means that drugs manufactured at this Aurangabad plant will be impounded by US customs when exported to America.

The stock fell 19 per cent to hit the low of Rs 1,066 on BSE and has declined over 27 per cent in the two sessions from Rs 1,644.05 on Wednesday.


The company expects a revenue loss of USD 100 million on annualized basis following the import alert.

At 12:15 hours, shares of the company were trading at Rs 1,168 a piece, down 11.20 per cent from previous close on BSE.

Read more about: wockhardt
Story first published: Friday, May 24, 2013, 23:38 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more